Reaffirms fiscal 2026 revenue guidance of $79 to $82 million and adjusted diluted EPS guidance of $1.03 to $1.10 Investor Day on January 21, 2026, to present new product vision and AI solutions ...

The "Human Vaccines - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Human Vaccines was valued at US$46.9 Billion in 2024 and is ...

Medincell (Paris:MEDCL) will hold a videoconference on Tuesday December 9, 2025 to present the half-year financial results (April 2025-September 2025)> Meeting in French, 6:00 pm (CET): Meeting in ...

Opening December 5th with extended hours and a focus on same-day needs, AcutePet Solon strengthens the region's access to high-quality veterinary care SOLON, OH / ACCESS Newswire / December 1, 2025 / ...

SOBIN-AD Also Reduces Aβ Plaque Formation and Synaptophysin Loss in Asymptomatic Disease in a Preclinical ...

Tampa-based orthopedic spine surgeon urges patients to explore holistic, evidence-based care before opting for surgery TAMPA, FL / ACCESS Newswire / December 1, 2025 / Dr. Drew Brown IV, MD, FAAOS, a ...

Apimeds Pharmaceuticals US, Inc. (NYSE American: APUS) announced a merger with MindWave Innovations Inc, uniting Apimeds’ late-stage, non-opioid pain-management biologic portfolio with MindWave’s ...

The Institute of Food Technologists (IFT), a nonprofit scientific association committed to advancing the science of food and its application across the global food system, is proud to announce that ...

Industry veteran brings two decades of platform commercialization experience in cell therapy, bioprocessing, and bioanalytics as Cellares prepares to support multiple clinical trials in ...

Sound Pharmaceuticals (SPI) is pleased to announce that the FDA has granted its investigational new drug, SPI-1005, ...

Compact, cable-free C-arm aims to maximize space and movement and allow greater flexibility and accessibility for everyday performancePatient-centric design featuring lateral wide-bore cone beam ...

Studies across all breast-cancer subtypes confirm Pathlight’s ultra-sensitive performance for early recurrence detection and treatment-response monitoringMORRISVILLE, N.C.--(BUSINESS ...